无症状和轻微症状的重度主动脉瓣狭窄患者左心室射血分数与死亡率的关系
该分析纳入1678例LVEF≥50%且无症状或轻微症状的重度主动脉瓣狭窄患者,按LVEF分为<55%、55%–59%、≥60%三组。LVEF<55%组5年生存率59±4%,低于LVEF≥60%组的72±2%和LVEF 55%–59%组的74±2%(p<0.001)。保守治疗和初始手术治疗中,LVEF<55%均与死亡率显著增加相关(校正HR分别为2.44和2.51);LVEF<55%者初始保守治疗较初始手术治疗死亡率更高(校正HR 2.70)。
要点
- LVEF<55%组5年生存率59±4%,低于LVEF≥60%组的72±2%和LVEF 55%–59%组的74±2%(p<0.001)。
- LVEF<55%者初始保守治疗较初始手术治疗死亡率更高(校正HR 2.70,95%CI 1.98–3.67;p<0.001)。
- LVEF 55%–59%组预后与LVEF≥60%组相当(初始保守治疗p=0.53,初始手术治疗p=0.36)。
核心结论
- 在重度主动脉瓣狭窄、LVEF保留且无症状或轻微症状的患者中,LVEF<55%是预后不良的标志,药物或手术治疗均提示这些患者应考虑在此阶段之前接受手术。
研究设计与样本
- 研究纳入1678例LVEF保留(≥50%)且无或轻微症状的重度主动脉瓣狭窄患者,分为LVEF<55%、55%–59%和≥60%三组,比较长期死亡率。
诊断标准与关键数值
- LVEF<55%组5年生存率59±4%,LVEF 55%–59%组74±2%,LVEF≥60%组72±2%(p<0.001)。初始保守治疗中,LVEF<55%组较LVEF≥60%组校正HR 2.44(95%CI 1.51–3.94;p<0.001);初始手术治疗中,LVEF<55%组较LVEF≥60%组校正HR 2.51(95%CI 1.58–4.00;p<0.001);LVEF 55%–59%组与LVEF≥60%组预后相当(初始保守治疗p=0.53,初始手术治疗p=0.36)。LVEF<55%者初始保守治疗较初始手术治疗校正HR 2.70(95%CI 1.98–3.67;p<0.001)。
临床应用与阅片要点
- 作者认为,LVEF<55%是重度主动脉瓣狭窄、LVEF保留且无症状或轻微症状患者预后不良的标志,应考虑在此阶段之前接受手术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study sought to determine the best left ventricular ejection fraction (LVEF) cutoff value to predict long-term mortality in patients with asymptomatic or minimally symptomatic severe aortic stenosis (AS) and LVEF ≥50% under conservative management and after surgical correction of AS.
BACKGROUND: Aortic valve replacement (AVR) is a Class I indication in asymptomatic patients with severe AS and LVEF <50%. However, this is an uncommon situation in asymptomatic severe AS (<1% of patients), usually occurring late in the course of the disease. No data are available concerning the prognostic value of LVEF in asymptomatic or minimally symptomatic AS patients with preserved LVEF (≥50%) in order to identify a LVEF threshold value associated with increased mortality.
METHODS: This analysis included 1,678 patients with preserved LVEF and no or minimal symptoms, with a diagnosis of severe AS. The population was divided into 3 groups: LVEF <55%, LVEF 55% to 59%, and LVEF ≥60%.
RESULTS: Five-year survival rate was 72 ± 2% for patients with LVEF ≥60%, 74 ± 2% for patients with LVEF between 55% and 59%, and 59 ± 4% for patients with LVEF <55% (p < 0.001). Under initially conservative or initially surgical management (surgery within 3 months after baseline echocardiography), patients with LVEF <55% displayed significant excess mortality compared to patients with LVEF≥ 60% (adjusted hazard ratio [HR]: 2.44 [95% confidence interval: 1.51 to 3.94]; p < 0.001 and 2.51 [95% confidence interval: 1.58 to 4.00]; p < 0.001, respectively), whereas patients with LVEF between 55% and 59% had comparable prognosis to those with LVEF ≥60% (p = 0.53 and p = 0.36, respectively). In patients with LVEF <55%, initial conservative management was associated with increased mortality compared to initial surgical management, even after covariate adjustment (adjusted hazard ratio [HR]: 2.70 [95% confidence interval: 1.98 to 3.67]; p < 0.001).
CONCLUSIONS: In patients with severe AS, preserved LVEF and no or minimal symptoms at the time of diagnosis, LVEF <55% is a marker of poor outcome, with medical or surgical management suggesting that these patients should be considered for surgery before this stage.
引用
- Bohbot Y, de Meester de Ravenstein C, Chadha G, et al. Relationship Between Left Ventricular Ejection Fraction and Mortality in Asymptomatic and Minimally Symptomatic Patients With Severe Aortic Stenosis. JACC Cardiovasc Imaging. 2018. PMID: 30448114. doi:10.1016/j.jcmg.2018.07.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。